Cytosorbents Corp Annual Income Tax Expense (Benefit) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Cytosorbents Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2023.
  • Cytosorbents Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Cytosorbents Corp annual Income Tax Expense (Benefit) for 2023 was -$814K, a 25.5% increase from 2022.
  • Cytosorbents Corp annual Income Tax Expense (Benefit) for 2022 was -$1.09M, a 48.4% decline from 2021.
  • Cytosorbents Corp annual Income Tax Expense (Benefit) for 2021 was -$736K, a 34.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.